Member Info for Bella6532

Cj62...'all i want is an explanation,'...you may still get one if the 40 day rule applies or they are waiting for PI's to get their shares. 😉

Gje306...' much better to let the nomad leak the info to the city,'....and make sure TW gets a wiff too...

Ah...how money begets money...

PL75....'Suspect they're all at it. Sitting about waiting for AIM companies to give them the chance to make a few bob at PIs expense'...

Errrrr! I can't believe you've only just realised that's why II's love fundraisers so much...for this very reason that's why I was , and still am, hoping that the European Speciality Fund is the likes of Medicxi because they would be in for the long haul.

Did someone say there was a 40 day rule which ends on 9 April?

So let's see what that brings in the way of news or is it just a postr of what we've already been told.

DTW...' the majority of fund managers do not have an understanding of the science at AVCT.'...they know very little about most of the companies they are invested in. Unfortunately well researched PI's tend to think II's must be the same or that they may know more. In my experience this s not the case unless they've gone Inside and even the information the might get then is put out to the wider market in a matter of days/weeks at the most.

I'd even bet some of the information put out by Avacta's partners doesn't even hit the desks in Avacta. We've had several postings on here which would have made nice news items for Avacta and we've seen nothing. They can't blame an NDA because the information was made public knowledge by the said company.

08-Mar-24 13:57:55 57.00 39,435 Unknown* 51.50 52.50 22.48k O

08-Mar-24 13:57:55 57.00 -39,435 Unknown* 51.50 52.50 -22.48k

Oh what a silly billy..did he press a 7 instead of 1...or?

BV...I think if they changed him and got someone in who really knew how to communicate then I think the problem might be much improved. As it stands we now have almost two years worth of financing. I'm not sure how long it will take the retail investors to get their new shares but that could be a reason for no news yet.

Experience

Avacta

9 years 10 months

Group Communications Director

Dec 2020 - Present 3 years 4 months

United Kingdom

Leading on corporate communications for Avacta Group, a UK based clinical stage biotech and diagnostics company.

• Creation and execution of Group communications strategy.

• Support senior leadership with considered counsel on reputation related matters and leading issues preparations and response.

• Managing partnerships with a range of advisors and agencies.

• Investor relations and working within the regulatory framework of being a publicly listed company.

• Media relations

Disagree BV...this is the guy they need to get rid of...

https://uk.linkedin.com/in/michaelvinegrad

Timster...Nah..not them..more likely the one who joined on 1 March with 28 neg posts...

Is that large trade why we had so many deramping on here...let's see who sticks around eh!

Somebody jumped the gun and put it through before order filled or what?

18-Mar-24 08:45:14 50.40 -1,000,000 Unknown* -504.00k O

18-Mar-24 08:45:14 50.40 1,000,000 Unknown* 504.00k

Timster...thought I'd just change the subject..haha...

18-Mar-24 17:05:27 50.75 253,358 Unknown* 50.50 51.00 128.58k O

18-Mar-24 17:05:24 50.75 243,500 Unknown* 50.50 51.00 123.58k

Don't any of you read RNS's...it's all in the 28 Feb Fundraising RNS. Due to the Placing/Fundraiser the Heights pricing will be recalculated and the calculation is all in there. Again, this was also all mentioned in the initital Heights deal RNS whereby if the SP dropped by a certain amount below their 95p the price would be recalculated....bla bla bla...

Https://avacta.com/wp-content/uploads/2023/06/FY22-ARA-Final-Print-Version.pdf

Geez...you could have worked out the companies cash position yourselves by reading the accounts. Don't blame others for what they choose to do with their shares.

And for those worried about share options...again read the accounts...AS let one lot lapse and has a bunch which are exciserable (and so does EF and TG) but have chosen not to.

Unlike some on here, there are not in it to make a quick buck...

BV...'Do you want to bet on that?' No, because I did not define what the clear update might be about so you will only try and wriggle out of the bet if the update does not contain what you want it to...Ha ha....!!!

Notrex...fundraising never goes down well with PIs sotting on a big paper loss. When you get large fundraisers bring large amounts of new shares to the market the SP will always suffer. I'm sure the company has been inundated with EMails re comms etc. Once the company gets out from under any comms restrictions they may be under, I'm sure we will get a very clear update.

Right now it's not worth bursting any more blood vessels unless you're here to further try and disrupt this BB which I'm sure you're not...are you? 🫣

'the bi-weekly trial (ie., a shorter dosing regimen) was always part of the plan.'...was it?...

I guess it all depends at what plan point you start from, but I don't think it was part of the original plan...

Discussions with FDA regarding the design and initiation of both the trial intended to support

331 accelerated approval and the postmarketing trial are recommended to provide evidence of

332 clinical benefit in an expeditious manner.,

So was the 2w introduced to obtain accelerated approval and the fundraise is becsuse they know they will need a postmarketing trial now too...and all points to reason for uptick in speed...all makes sense to me...